Page last updated: 2024-09-05

etravirine and AIDS Seroconversion

etravirine has been researched along with AIDS Seroconversion in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	4 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boven, K; Esposito, S; Feiterna-Sperling, C; Giaquinto, C; Kakuda, TN; Königs, C; Leemans, R; Mack, R; Peeters, I; Peeters, M; Rosso, R; Sinha, R; Viscoli, C	1
Bigoloni, A; Carini, E; Castagna, A; Cossarini, F; Galli, L; Gianotti, N; Lazzarin, A; Nozza, S; Piatti, P; Salpietro, S; Spagnuolo, V; Vinci, C	1
Arribas, JR; Bernardino, JI; Estebanez, M; García-Bujalance, S; Martin-Quirós, A; Mingorance, J; Pérez-Valero, I; Ruiz-Carrascoso, G; Stella-Ascariz, N; Zamora, FX	1
Bouzas, MB; Cecchini, DM; Fernandez Giuliano, S; Martinez, MG; Rodriguez, CG; Zapiola, I	1

Trials

1 trial(s) available for etravirine and AIDS Seroconversion

Article	Year
Pharmacokinetics and short-term safety and tolerability of etravirine in treatment-experienced HIV-1-infected children and adolescents. AIDS (London, England), 2012, Feb-20, Volume: 26, Issue:4 Topics: Adolescent; Anti-HIV Agents; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Seropositivity; Humans; Lopinavir; Male; Nitriles; Pyridazines; Pyrimidines; Ritonavir; RNA, Viral; Treatment Outcome; Viral Load	2012

Article

Year

Pharmacokinetics and short-term safety and tolerability of etravirine in treatment-experienced HIV-1-infected children and adolescents.

AIDS (London, England), 2012, Feb-20, Volume: 26, Issue:4

Topics: Adolescent; Anti-HIV Agents; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Seropositivity; Humans; Lopinavir; Male; Nitriles; Pyridazines; Pyrimidines; Ritonavir; RNA, Viral; Treatment Outcome; Viral Load

2012

Other Studies

3 other study(ies) available for etravirine and AIDS Seroconversion

Article	Year
Long-term glucose tolerance in highly experienced HIV-infected patients receiving nucleoside analogue-sparing regimens. AIDS (London, England), 2012, Sep-10, Volume: 26, Issue:14 Topics: Anti-HIV Agents; Blood Glucose; Cyclohexanes; Darunavir; Fasting; Glucose Tolerance Test; HIV Protease Inhibitors; HIV Seropositivity; HIV-1; Humans; Insulin; Insulin Resistance; Maraviroc; Nitriles; Pyridazines; Pyrimidines; Pyrrolidinones; Raltegravir Potassium; Ritonavir; Sulfonamides; Treatment Outcome; Triazoles; Viral Load	2012
Is etravirine and two nucleosides an option for HIV with an isolated K103N mutation? AIDS (London, England), 2013, Jan-02, Volume: 27, Issue:1 Topics: Adenine; Adult; Anti-HIV Agents; Asparagine; Deoxycytidine; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; Emtricitabine; Female; Genotype; HIV Seropositivity; HIV-1; Humans; Lysine; Male; Mutation; Nitriles; Organophosphonates; Pyridazines; Pyrimidines; Reverse Transcriptase Inhibitors; Tenofovir	2013
Etravirine resistance mutations in HIV-infected pregnant women. HIV medicine, 2013, Volume: 14, Issue:2 Topics: Anti-HIV Agents; Argentina; Drug Resistance, Viral; Female; HIV Seropositivity; Humans; Mutation; Nitriles; Phenotype; Pregnancy; Pyridazines; Pyrimidines; Treatment Failure	2013